QHM-2025-80851 Appleby Medical Practice - Local Enhanced Services

" This procurement, classified under the health services industry category, involves services such as Near Patient Testing, Warfarin Monitoring, and Hormonal Injection Administration. The process is under the Direct Award Process A from the Health Care Services (Provider Selection Regime) regulations 2023, which does not require adherence to traditional procurement rules. The contract concerns the UKC region, specifically set in Sunderland and Appleby.

The current stage is the Award phase, with the contract spanning from 1 April 2025 to 31 March 2026. The procurement method used was limited, with no prior publication of competition, as it falls outside certain directive scopes. This tender presents significant opportunities for businesses in the healthcare sector, especially ones offering specific medical services.

The contracting opportunity is best suited for entities with capabilities in health service provision, specifically those with experience in drug and warfarin monitoring, hormonal injection services, and minor injuries care. Existing providers in these niches could leverage this opportunity to expand their service offerings and solidify their presence in regional healthcare supply chains. Given the direct award process, businesses with the unique capability to provide these services can benefit from reduced competition and a streamlined procurement process.